H2AX and lymphoma: Western analysis of PARP and phosphorylated H2AX expression levels in one representative cell line for each lymphoma subtype confirmed that addition of the ATM inhibitor to romidepsin increases the apoptotic effects of the HDACi (Figure 4B).